Table 2 Operative and pathologic outcomes of 84 bladder cancer patients
Variable | Total cases | Three-port LRC (n = 30) | Five-port LRC (n = 54) | P value |
|---|---|---|---|---|
Operative time, [min,mean ± SD] | 276.62 ± 41.45 | 271.30 ± 24.03 | 279.57 ± 48.47 | 0.299 |
EBL, [mL,median (range)] | 80 (30–300) | 65 (40–300) | 90 (30–300) | 0.352 |
Pathology type, [cases (%)] | 0.177 | |||
Transitional cell carcinoma | 83 (98.81) | 29 (96.67) | 54 (100) | |
Squamous cell carcinoma | 1 (1.19) | 1 (3.33) | 0 | |
Incidental prostate adenocarcinoma,[cases(%)] | 5 (5.95) | 3 (10.00) | 2 (3.70) | 0.243 |
Pathologic T stage, [cases (%)] | 0.166 | |||
1 | 30 (35.71) | 6 (20.00) | 24 (44.44) | |
2 | 32(38.10) | 14 (46.66) | 18 (33.33) | |
3 | 18 (21.43) | 8 (26.67) | 10 (18.52) | |
4 | 4 (4.76) | 2 (6.67) | 2 (3.71) | |
Pathologic N stage, [cases (%)] | 0.563 | |||
0 | 75 (89.29) | 26 (86.67) | 49 (90.74) | |
≥ 1 | 9 (10.71) | 4 (13.33) | 5 (9.26) | |
Time to out-of-bed activity, [d, median (range)] | 2 (1–4) | 2 (1–4) | 2 (1–4) | 0.436 |
Time to passage of flatus, [d, median (range)] | 3(2–5) | 3(2–5) | 3(2–5) | 0.084 |
Time to regular diet, [d, median (range)] | 5(4–13) | 5(4–13) | 6(4–12) | 0.065 |
Time to pelvic drain removal, [d, median (range)] | 9(5–18) | 8(5–17) | 10(5–18) | 0.084 |
Hospital stay after operation, [d, median (range)] | 11.5(7–28) | 11(8–22) | 12(7–28) | 0.922 |
Median treatment cost [$, median (range)]* | 13 474 (8 411–24 683) | 12 453 (8 411–20 326) | 14 134 (8 794–24 683) | 0.021 |